Matthew McManus

Matthew McManus

Ordförande på
Ansa Biotechnologies, Inc.

Förmögenhet: 397 471 $ per 2026-05-31

57 år
Health Technology
Consumer Services
Health Services

Profil

Matthew F.
McManus
is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-02-01 7 691 ( 0 % ) 397 471 $ 2026-05-31

Aktiva positioner av Matthew McManus

FöretagPositionStart
Ordförande 2023-02-22

Tidigare kända positioner av Matthew McManus

FöretagPositionSlut
BIO-TECHNE CORPORATION Företagsledare/Principal 2026-03-01
AZENTA, INC. Verksamhetschef 2022-10-14
Verkställande Direktör -
Företagsledare/Principal 2010-01-02
PROCTER & GAMBLE COMPANY Företagsledare/Principal -
Se detaljerna i Matthew McManuss erfarenhet

Matthew McManuss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

19

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Consumer Non-Durables

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Matthew McManus